For the seventeenth time in its recorded history, the Democratic Republic of Congo is locked in a struggle with Ebola — but this time, the scale is without precedent. More than two thousand lives have been lost across five eastern provinces already fractured by conflict, and the virus is moving faster than the systems built to stop it. It is a grim reminder that disease does not wait for peace, payment, or a perfect vaccine — and that the distance between a contained outbreak and a historic catastrophe is often measured in the smallest human failures.
DRC Ebola outbreak death toll surpasses 2,000 as largest outbreak in country's history accelerates
An Ebola outbreak has killed 2,011 people out of 4,381 confirmed cases in the Democratic Republic of Congo, with health workers striking over lack of payment hampering response efforts.
Officials are chasing the virus, the virus is ahead of us.
Mark
So we're looking at 2,011 deaths out of 4,381 cases. That's a 45.9 percent fatality rate. How does that compare to what we've seen before?
Mimi
The 2018-2020 outbreak in the DRC killed nearly 2,300 people from 3,500 cases. This one is already close to that, but it's spreading faster and affecting more people. The case fatality rate is actually slightly lower than some previous outbreaks, but the sheer scale is what's alarming.
Luke
Wait—if the fatality rate is lower, why is this considered worse?
Mimi
Because it's infecting more people overall. A lower fatality rate applied to a much larger number of cases still means more deaths. And it's the largest outbreak in DRC history, possibly the largest ever recorded anywhere.
Mark
The source says it was declared May 15 but had been spreading for weeks before that. How much earlier are we talking about?
Luke
The source doesn't specify. It just says "several weeks." That's vague. We don't know if that's three weeks or eight weeks, which matters for understanding how long it went undetected.
Mimi
True. But the point is there was a lag between when it started circulating and when it was officially recognized. That's common with Ebola in conflict zones—infrastructure is weak, surveillance is limited.
Mark
Tell me about the vaccine situation. Ervebo exists, but it was designed for a different strain?
Mimi
Exactly. Ervebo works against Zaire Ebola. The strain spreading now is Bundibugyo, which is rare. Animal studies suggest Ervebo might offer some cross-protection, but that's not proven in humans yet. That's why WHO is recommending a full-scale trial.
Luke
So they're essentially testing whether a vaccine designed for one strain might work against another. That's not a guarantee.
Mimi
No. But it's the only approved vaccine available right now. Two other candidates specific to Bundibugyo are in early human trials, and a third is still in development.
Mark
And the health workers striking—that's a real problem for containment?
Mimi
Absolutely. Without them, you can't trace contacts, isolate cases, or ensure safe burials. The response is already outpacing the virus, and unpaid workers make that worse.
Luke
The source says officials are "chasing the virus, the virus is ahead of us." That's a direct quote from the WHO regional director. It's stark language, but it's also what he actually said.
El Pulso
- The DRC's 17th Ebola outbreak has killed 2,011 people from 4,381 confirmed cases, a 45.9% fatality rate that places it on course to surpass every recorded outbreak in history.
- The rare Bundibugyo strain has no approved vaccine, leaving health authorities scrambling to repurpose Ervebo — a tool designed for a different enemy — while two other candidates remain in early trials.
- Armed conflict across five eastern provinces has shattered the infrastructure needed for containment, and health workers have walked off the job after months without pay, leaving contact tracing and safe burials dangerously understaffed.
- WHO officials have stated plainly that responders are chasing the virus — and the virus is winning, spreading faster than the response can reach it.
- A full-scale human trial of Ervebo for cross-protection against Bundibugyo has been recommended by WHO vaccine experts, offering a narrow thread of hope in an otherwise deteriorating picture.
For the seventeenth time in its recorded history, the Democratic Republic of Congo is locked in a struggle with Ebola — but this time, the scale is without precedent. More than two thousand lives have been lost across five eastern provinces already fractured by conflict, and the virus is moving faster than the systems built to stop it. It is a grim reminder that disease does not wait for peace, payment, or a perfect vaccine — and that the distance between a contained outbreak and a historic catastrophe is often measured in the smallest human failures.
The Ebola outbreak in the Democratic Republic of Congo has now claimed 2,011 lives from 4,381 confirmed cases — figures that make this the largest outbreak in the country's history and potentially the largest anywhere on record. The previous benchmark was the 2018–2020 DRC surge, which killed nearly 2,300 people from a smaller case count. The current trajectory suggests that record will fall.
This is the DRC's seventeenth encounter with Ebola, but it carries a distinction all its own. The strain circulating through five eastern provinces is Bundibugyo, a rare variant for which no approved vaccine exists. That absence has forced global health authorities toward improvisation: the WHO's vaccine experts have recommended launching full-scale human trials of Ervebo — the only licensed Ebola vaccine, developed against the more common Zaire strain — on the basis of early animal data suggesting it may offer partial cross-protection. Two Bundibugyo-specific vaccines are already in early trials; a third remains in development.
The response is fighting on multiple fronts simultaneously. Eastern Congo's ongoing armed conflict has destabilized the very provinces where the virus is spreading most aggressively, making logistics, access, and trust all harder to secure. Compounding this, health workers have gone on strike — unpaid since the outbreak was formally declared in May, despite weeks of prior circulation. Without them, the core machinery of containment collapses: contact tracing stalls, isolation breaks down, safe burials go undone.
Gavi's chief executive described the situation as already historic. The WHO's Africa director put it more starkly: officials are chasing the virus, and the virus is ahead. Fifty years after Ebola was first identified near the river that gave it its name, the DRC is facing its most devastating encounter with the disease yet.
The Ebola outbreak spreading through the Democratic Republic of Congo has now killed 2,011 people. That number comes from 4,381 confirmed cases recorded as of Tuesday, according to Congolese health officials. The virus was formally declared on May 15, though it had already been circulating for weeks before that announcement came.
This is the DRC's seventeenth Ebola surge in its recorded history, but it carries a distinction that sets it apart from all the others. It is already the largest outbreak the country has ever experienced, and epidemiologists warn it could become the largest Ebola outbreak anywhere on record. The previous record holder in the DRC was the 2018-2020 outbreak, which killed nearly 2,300 people from 3,500 confirmed cases. The current toll is closing in on that figure, and the trajectory suggests it will surpass it. The case fatality rate stands at 45.9 percent—meaning that of every hundred people who contract the virus, roughly forty-six will die.
The outbreak is concentrated in five eastern provinces of the DRC, regions already destabilized by armed conflict. This geography matters because it complicates everything about the response. Aid workers on the ground report that the virus is spreading faster than the response infrastructure can contain it. The strain circulating now is Bundibugyo, a rare variant of Ebola for which no specific vaccine currently exists. This absence has forced health authorities and global partners to consider unconventional approaches.
On Friday, the World Health Organization's vaccine experts recommended launching a full-scale human trial of Ervebo, the only approved Ebola vaccine available today. Ervebo was developed and tested against the Zaire strain, the more common form of the virus. Early data from animal studies suggest it may offer some cross-protection against the Bundibugyo strain now spreading in the DRC. Two other Bundibugyo-specific vaccines are already in early human trials, with a third still in development. The hope is that one of these approaches will provide protection, but the timeline remains uncertain.
The response effort faces another obstacle: health workers have gone on strike. Since the outbreak was declared in May, many have not been paid for their work. Without them, the machinery of containment—contact tracing, case isolation, safe burial practices—grinds to a halt. Sania Nishtar, chief executive of Gavi, the global vaccine alliance, described the situation plainly: the outbreak is already the largest in the country's history and could become the largest ever recorded anywhere. Mohamed Yakub Janabi, the WHO's regional director for Africa, put it differently at a news conference: officials are chasing the virus, but the virus is ahead of them.
Ebola spreads through contact with bodily fluids and causes a hemorrhagic fever. The virus was first identified in 1976 near the Ebola River in what is now Congo. Fifty years later, the DRC is facing its most severe encounter with the disease it shares a name with.
Citas Notables
Already the largest outbreak in the country's history and could well become the largest outbreak ever— Sania Nishtar, chief executive of Gavi vaccine alliance
Officials are chasing the virus, the virus is ahead of us— Dr. Mohamed Yakub Janabi, WHO regional director for Africa
Quieres la nota completa?
Lee el original en Euronews ↗
Health & Medicine